[144] Life360, Inc. SEC Filing
Rhea-AI Filing Summary
Life360, Inc. (LIF) submitted a Form 144 disclosing a proposed sale of 500 common shares through Fidelity Brokerage Services with an aggregate market value of $37,205.00 and an approximate sale date of 08/11/2025 on NASDAQ. The filing shows those 500 shares were acquired by restricted stock vesting on 09/19/2024 and paid as compensation. The document also lists prior sales by the same person totaling 6,387 shares for $405,685.40 during the past three months and reports 76,528,724 shares outstanding. The form includes the required Rule 144 certification language and does not list a Rule 10b5-1 plan adoption date.
Positive
- Planned sale fully disclosed under Rule 144 with broker, share count, market value, and exchange specified
- Acquisition source provided: 500 shares were acquired by restricted stock vesting on 09/19/2024 as compensation
- Past three months activity disclosed: seven sales totaling 6,387 shares for $405,685.40, allowing investors to quantify insider dispositions
Negative
- None.
Insights
TL;DR Insider files to sell 500 shares; prior small sales total 6,387 shares for $405,685.40 — filing appears routine and procedural.
The Form 144 documents a proposed sale executed through Fidelity and identifies the shares as originating from a restricted stock vesting event on 09/19/2024 that was compensation. The filing provides transparent disclosure of recent dispositions by the same person, listing seven sales in the prior three months. The absolute values and counts are stated on the form and allow investors to quantify insider activity; the filing includes standard Rule 144 attestations.
TL;DR Filing follows Rule 144 disclosure requirements and contains required attestations; no 10b5-1 plan date is provided on the form.
The document contains the customary representation that the seller is not aware of undisclosed material adverse information and includes the section for plan adoption date under Rule 10b5-1, which is not filled in. From a governance viewpoint the filing is a routine insider disclosure; it documents acquisition source (restricted stock vesting) and recent sales but does not indicate an affirmative trading-plan adoption date on the form itself.